TRIPLIXAM® – Perindopril arginine – Indapamide – Amlodipine 09.06.2025 TRIPLIXAM® – Perindopril arginine – Indapamide – Amlodipine #CVRISK#Hypertension 1
ARTICLE | Additional Information on Tolerability Hypertension and CV risk 05.06.2025 ARTICLE | Additional Information on Tolerability #CVRISK#Hypertension 2
LEAFLET | World Adherence Day DiabetesDyslipidaemiaHypertension and CV risk 28.05.2025 LEAFLET | World Adherence Day ##Adherence#CVRISK#Diabetes#Dyslipidaemia#Hypertension 10
VIDEO | In the Real-World your treatment choice makes A difference Hypertension and CV risk 23.05.2025 VIDEO | In the Real-World your treatment choice makes A difference #CVRISK#Hypertension 17
VIDEO| Mode of Action – Bisoprolol-Perindopril Hypertension and CV risk 23.05.2025 VIDEO| Mode of Action – Bisoprolol-Perindopril #CVRISK#Hypertension 6
CPD Article | The argument for and against kindness in ethics 15.05.2025 CPD Article | The argument for and against kindness in ethics 14
VIDEO | Adherence Matters: The key to optimising clinical outcomes DiabetesDyslipidaemiaHypertension and CV risk 08.05.2025 VIDEO | Adherence Matters: The key to optimising clinical outcomes ##Adherence#CPD#CPDPoints#CVRISK#Diabetes#Dyslipidaemia#Hypertension#Webinar 1 51
ARTICLE | Unblocking the burden in Salt Sensitive Hypertension (SSH) Hypertension and CV risk 14.04.2025 ARTICLE | Unblocking the burden in Salt Sensitive Hypertension (SSH) #CVRISK#Hypertension 3 60
ARTICLE | The Essentials: GLICLAZIDE MR Diabetes 11.04.2025 ARTICLE | The Essentials: GLICLAZIDE MR #Diabetes 30
ARTICLE | Is Glycaemic Control relevant? Diabetes 11.04.2025 ARTICLE | Is Glycaemic Control relevant? #CPD#CPDPoints#Diabetes 3 70